| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | EVP, Drug Discovery | Stock Option (Right to Buy) | 65,000 | 11 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | 11 Mar 2024 | 1 | $0 | 4 | EVP, Drug Discovery | 12 Mar 2024, 18:37 |
| XENE | Xenon Pharmaceuticals Inc. | 10 Mar 2023 | 1 | $0 | 4 | EVP, Drug Discovery | 14 Mar 2023, 16:27 |
| XENE | Xenon Pharmaceuticals Inc. | 12 Aug 2022 | 7 | -$2,212,140 | 4 | EVP, Drug Discovery | 16 Aug 2022, 17:36 |
| XENE | Xenon Pharmaceuticals Inc. | 10 Mar 2022 | 1 | $0 | 4 | EVP, Drug Discovery | 14 Mar 2022, 16:10 |
| XENE | Xenon Pharmaceuticals Inc. | 04 Mar 2022 | 12 | -$1,567,665 | 4 | EVP, Drug Discovery | 08 Mar 2022, 18:32 |